Envista (NYSE:NVST) Updates FY 2026 Earnings Guidance

Envista (NYSE:NVST) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.350-1.450 for the period, compared to the consensus earnings per share estimate of 1.410. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Wells Fargo & Company upped their price objective on Envista from $21.00 to $26.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Leerink Partners set a $35.00 price objective on Envista and gave the stock an “outperform” rating in a research report on Friday, February 6th. Citigroup began coverage on Envista in a research report on Wednesday, April 15th. They issued a “neutral” rating and a $29.00 price objective on the stock. Barclays increased their target price on Envista from $24.00 to $34.00 and gave the company an “overweight” rating in a research report on Wednesday, February 11th. Finally, Wall Street Zen upgraded Envista from a “buy” rating to a “strong-buy” rating in a research report on Monday, January 26th. Six investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $28.58.

Envista Trading Down 8.3%

Shares of NYSE NVST traded down $2.25 during trading on Thursday, hitting $24.83. 8,017,325 shares of the company were exchanged, compared to its average volume of 2,801,953. Envista has a 12-month low of $16.41 and a 12-month high of $30.42. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.04 and a current ratio of 2.38. The company has a fifty day moving average price of $26.63 and a 200-day moving average price of $24.03. The firm has a market capitalization of $4.05 billion, a PE ratio of 88.30, a P/E/G ratio of 1.79 and a beta of 0.92.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.31 by $0.05. The business had revenue of $705.50 million for the quarter, compared to analyst estimates of $680.04 million. Envista had a return on equity of 6.54% and a net margin of 1.73%.The company’s quarterly revenue was up 14.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, equities research analysts expect that Envista will post 1.4 EPS for the current year.

Insider Activity

In related news, SVP Mischa Reis sold 9,675 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total transaction of $290,250.00. Following the completion of the sale, the senior vice president directly owned 32,382 shares of the company’s stock, valued at approximately $971,460. This trade represents a 23.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.99% of the company’s stock.

Trending Headlines about Envista

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Q1 beat — Envista delivered $0.36 EPS vs. $0.31 consensus and revenue of $705.5M vs. ~$680M, with organic revenue up ~14% year-over-year, showing broad-based strength. Envista Reports First Quarter 2026 Results
• Positive Sentiment: Analyst upgrade — Robert W. Baird raised its price target to $31 and kept an Outperform rating, signaling buy-side confidence in the company’s growth trajectory. Benzinga
• Positive Sentiment: Street commentary highlights new growth drivers and operating leverage potential that could expand margins if revenue momentum continues. Envista: Spotlight On Q1 Outperformance And New Growth Drivers
• Neutral Sentiment: FY?2026 guidance set to $1.35–$1.45 EPS (midpoint ~1.40), essentially in line with consensus — helps visibility but doesn’t materially raise expectations. Envista FY2026 Guidance (Press Release/Slides)
• Neutral Sentiment: Earnings call and transcript provide color on geographic trends, product mix, and margin drivers — useful for judging sustainability of the beat. Q1 2026 Earnings Call Transcript
• Negative Sentiment: Profitability concerns — net margin remains low (~1.7%) and valuation is rich (high P/E), which could limit upside if margin expansion or guidance beats don’t materialize. Analysts and metric reviews flagged areas to monitor. Here’s What Key Metrics Tell Us About Envista (NVST) Q1 Earnings

Institutional Trading of Envista

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Royal Bank of Canada grew its position in Envista by 26.6% in the 1st quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock valued at $401,000 after acquiring an additional 4,885 shares in the last quarter. Millennium Management LLC grew its position in Envista by 218.6% in the 1st quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock valued at $6,627,000 after acquiring an additional 263,442 shares in the last quarter. Goldman Sachs Group Inc. grew its position in Envista by 39.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock valued at $10,859,000 after acquiring an additional 177,630 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Envista by 15.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock valued at $9,821,000 after acquiring an additional 76,246 shares in the last quarter. Finally, Prudential Financial Inc. grew its position in Envista by 22.1% in the 2nd quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock valued at $367,000 after acquiring an additional 3,395 shares in the last quarter.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.